CLINICAL_TRIALS
trial_result
· 2025-04-13
Clinical Trial Update: Diet Treatment Glucose Transporter Type 1 Deficiency (G1D) [Phase 2]
Summary
Phase 2 study update evaluating a diet-based treatment for Glucose Transporter Type 1 Deficiency Syndrome (GLUT1DS), with epilepsy as a co-occurring condition; …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: GLUT1DS1, Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2025-04-13